TipRanks
Go Ultimate55% OFF

AFT Pharmaceuticals Ltd. (AFT) Ownership - Who Owns AFT Pharmaceuticals Ltd.?

AFT Pharmaceuticals Ltd. (AFT) Ownership Overview

  • 0.04% Mutual Funds
  • <0.01% ETFs
  • 99.95% Public Companies and Individual Investors

The ownership structure of AFT Pharmaceuticals Ltd. (NZ:AFT) stock is a mix of institutional, retail, and individual investors. Approximately 0.05% of the company’s stock is owned by Institutional Investors, and 99.95% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

NZ:AFT top shareholders
Holder# of SharesType% HoldingValue
Commonwealth International Series Trust46,000Institution0.04%118,634
Dimensional1,365Institution<0.01%3,520

Top Mutual Fund Holders

NZ:AFT top mutual fund holders
Holder# of SharesType% HoldingValue
Commonwealth International Series Trust46,000Institution0.04%118,634

Top ETF Holders

NZ:AFT top ETF holders
Holder# of SharesType% HoldingValue
Dimensional, DFIS ETF1,337Institution<0.01%3,503
Dimensional, DXIV ETF28Institution<0.01%73

FAQ

What percentage of AFT Pharmaceuticals Ltd. (NZ:AFT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.05% of AFT Pharmaceuticals Ltd. (NZ:AFT) stock is held by institutional investors: 0.04% by mutual funds and <0.01% by ETFs.
What percentage of AFT Pharmaceuticals Ltd. (NZ:AFT) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.95% of AFT Pharmaceuticals Ltd. (NZ:AFT) stock is held by public companies and individual investors.
Who owns the most shares of AFT Pharmaceuticals Ltd. (NZ:AFT)?
Commonwealth International Series Trust owns the most shares of AFT Pharmaceuticals Ltd. (NZ:AFT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.